BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 7, 2011
View Archived Issues
Esmirtazapine may impair day-after driving performance
Read More
Yokukansan ameliorates aspects of two autism spectrum disorders
Read More
SHIFT substudy evaluates ivabradine in patients on background therapy for heart failure
Read More
Doxazosin versus tizanidine assessed in children with voiding dysfunction
Read More
Merck & Co. reports discovery of new tachykinin NK1 receptor antagonists
Read More
EVOLVE-1 trial assesses mTOR inhibitor plus best supportive care in hepatocellular carcinoma
Read More
Merck KGaA presents novel TGFR-1 inhibitors
Read More
KBP Biosciences patents novel antibacterial prodrugs of carbapenem derivatives
Read More
New prostaglandin E synthase inhibitors synthesized
Read More
Elevation Pharmaceuticals begins phase II trial of nebulized EP-101 in COPD
Read More
New substituted trifluoromethanes disclosed
Read More
Completed phase IIa study provides promising data on VX-509 in rheumatoid arthritis
Read More
Durect advances U.S. phase III Posidur trial
Read More
Adolor completes reacquisition of all rights to alvimopan
Read More
BioDelivery Sciences reports preliminary phase I data on BEMA-buprenorphine/naloxone
Read More
RIKEN identifies novel IFN-gamma inducers
Read More
Discovery Labs submits complete response to FDA for Surfaxin
Read More
Theratechnologies initiates new phase II tesamorelin study
Read More
Boehringer Ingelheim provides updates on two phase II afatinib trials in breast cancer
Read More
Basilea Pharmaceutica begins second phase I trial of sulfactam antibiotic BAL-30072
Read More
Furiex reports promising phase II data on MuDelta in D-IBS
Read More
SARcode BioScience initiates phase III trial of SAR-1118 ophthalmic solution
Read More
European Commission grants PUMA for Buccolam
Read More
AB Science commences enrollment in international masitinib trial in MS
Read More
MediGene and Pharmanova enter agreement for Veregen
Read More
University of Pennsylvania awards grant to OPKO for MPS I therapy
Read More